For The Better

Editas Medicine and Bluebird Bio have been favorite targets for short-sellers lately.

These companies are poised to benefit from a shift toward AI.

These businesses can justify their recent run-ups.

The answer may come from focusing on trends in the company’s profitability.

Can the company turn things around?

Markets gave back some ground after consideration of the Fed’s latest interest rate decision.

I continue to add to this high-quality dividend growth stock.

Different, promising, and down between 10% to 40% from their all-time highs, these companies are compelling choices.

The streaming companies are focused on refining their operations.

Wall Street is much more optimistic about the e-commerce platform provider right now.

Singapore operations carried the business last quarter, but Macao is staging a comeback.

Each of these dominant companies has a compelling investment case.

With many tech stocks’ valuations looking stretched, here’s an investment idea beyond tech that you won’t want to pass up.

Sonos is focusing on cutting costs as demand sinks.

ARK Analyst Ali Urman and Dr. Jonathan Weissman discuss CRISPR and how the genetic engineering tool can be used for drug development.

Online store builder Shopify is definitely in the right place at the right time.

These top stocks could deliver both in the near term and over time.

These digital specialists have bright long-term growth outlooks.

These companies have easy-to-understand business models and track records of delivering above-average returns.